Klin Onkol 2006; 19(Suppl): 85-87.
Keywords: Li-Fraumeni syndrome, germline mutation in TP53 gene, hereditary predisposititon to cancer, genetic testing of Li-Fraumeni syndrome
Authors: Foretová Lenka, Navrátilová Marie, Petráková Katarína, Palácová Markéta, Kalábová Renata, Puchmajerová Alena, Novotná Kamila, Sedláček Zdeněk2006-04-30:Cases of LiFraumeni syndrome: diagnostic and preventive possibilities
Keywords: Li-Fraumeni syndrome, germline mutation in TP53 gene, hereditary predisposititon to cancer, genetic testing of Li-Fraumeni syndrome
Authors: Foretová Lenka, Navrátilová Marie, Petráková Katarína, Palácová Markéta, Kalábová Renata, Puchmajerová Alena, Novotná Kamila, Sedláček Zdeněk2006-04-30:Cases of LiFraumeni syndrome: diagnostic and preventive possibilities
Klin Onkol 2006; 19(Suppl): 88-90.
Keywords: Genetic mutation carriers, surveillance programme, profylactic surgery
Authors: Petráková Katarína, Palácová Markéta, Foretová Lenka, Kalábová Renata2006-04-30:Algorithm of preventive care in genetically determined malignancies
Keywords: Genetic mutation carriers, surveillance programme, profylactic surgery
Authors: Petráková Katarína, Palácová Markéta, Foretová Lenka, Kalábová Renata2006-04-30:Algorithm of preventive care in genetically determined malignancies
Klin Onkol 2006; 19(Suppl): 91.
Keywords: high risk for hereditary breast cancer, surveillance, breast magnetic resonance imaging
Authors: Schneiderová Monika, Bartoňková Helena2006-04-30:Breast Magnetic Resonance Imaging in Surveillance of Women at High Risk for Breast Cancer
Keywords: high risk for hereditary breast cancer, surveillance, breast magnetic resonance imaging
Authors: Schneiderová Monika, Bartoňková Helena2006-04-30:Breast Magnetic Resonance Imaging in Surveillance of Women at High Risk for Breast Cancer
Klin Onkol 2006; 19(Suppl): 92-100.
Keywords: prophylactic mastectomy, indication, breast reconstruction
Authors: Dražan Luboš2006-04-30:Prophylactic mastectomy and its indications in high-risk women
Keywords: prophylactic mastectomy, indication, breast reconstruction
Authors: Dražan Luboš2006-04-30:Prophylactic mastectomy and its indications in high-risk women
Klin Onkol 2006; 19(Suppl): 101-104.
Keywords: hereditary predisposition to breast and ovarian cancer, prevention, preventive adnexectomy, prophylactic mastectomy
Authors: Foretová Lenka, Navrátilová Marie, Vítová Hana, Hanousková Dita, Dvořáčková Blanka, Kalábová Renata, Palácová Markéta, Schneiderová Monika, Petráková Katarína2006-04-30:Prevention care in women with hereditary breast/ovarian cancer – the results of questionnaire study, prevention at the Masaryk Memorial Cancer Institute
Keywords: hereditary predisposition to breast and ovarian cancer, prevention, preventive adnexectomy, prophylactic mastectomy
Authors: Foretová Lenka, Navrátilová Marie, Vítová Hana, Hanousková Dita, Dvořáčková Blanka, Kalábová Renata, Palácová Markéta, Schneiderová Monika, Petráková Katarína2006-04-30:Prevention care in women with hereditary breast/ovarian cancer – the results of questionnaire study, prevention at the Masaryk Memorial Cancer Institute
Klin Onkol 2006; 19(2): 121-123.
Keywords: Liver metastases from colorectal cancer, liver resection, multimodal treatment
Authors: Ablorsu Emmanuel, Kothaj (1951-) Peter2006-04-15:Current role of surgery in treatment of liver metastases from colorectal cancer.
Keywords: Liver metastases from colorectal cancer, liver resection, multimodal treatment
Authors: Ablorsu Emmanuel, Kothaj (1951-) Peter2006-04-15:Current role of surgery in treatment of liver metastases from colorectal cancer.
Klin Onkol 2006; 19(2): 124-129.
Keywords: cervical carcinoma, ovarian carcinoma, chromosomal aberrations, genetic alterations, cytogenetics.
Authors: Krkavcová M., Jančárková Natália, Janashia M., Křítková Alena, Pexidrová M.2006-04-15:Detection and occurence of the chromosomal aberrations in malignant tumours of cervix and ovary.
Keywords: cervical carcinoma, ovarian carcinoma, chromosomal aberrations, genetic alterations, cytogenetics.
Authors: Krkavcová M., Jančárková Natália, Janashia M., Křítková Alena, Pexidrová M.2006-04-15:Detection and occurence of the chromosomal aberrations in malignant tumours of cervix and ovary.
Klin Onkol 2006; 19(2): 130-137.
Keywords: medulloblastoma, chemotherapy, prognostic factors, risk category, molecular targeted therapy
Authors: Pavelka Zdeněk, Zitterbart Karel2006-04-15:Medulloblastoma (PNET) in children - present management.
Keywords: medulloblastoma, chemotherapy, prognostic factors, risk category, molecular targeted therapy
Authors: Pavelka Zdeněk, Zitterbart Karel2006-04-15:Medulloblastoma (PNET) in children - present management.
Klin Onkol 2006; 19(2): 137.
Keywords: review
Authors: Abrahámová Jitka2006-04-15:book review: Nádory testis, diagnostika a liečba
Keywords: review
Authors: Abrahámová Jitka2006-04-15:book review: Nádory testis, diagnostika a liečba
Klin Onkol 2006; 19(2): 138-142.
Keywords: metallothionein, MT, diagnostics, melanoma, breast cancer, colon cancer, Brdicka reaction
Authors: Petrlová Jitka, Blaštík O., Průša Richard, Kukačka Jiří, Mikelová R., Stiborová Marie, Vojtěšek Bořivoj, Adam Vojtěch, Zítka Ondřej, Eckschlager Tomáš, Kizek René2006-04-15:Determination of metallothionein content in patients with breast cancer, colon cancer, and malignant melanoma.
Keywords: metallothionein, MT, diagnostics, melanoma, breast cancer, colon cancer, Brdicka reaction
Authors: Petrlová Jitka, Blaštík O., Průša Richard, Kukačka Jiří, Mikelová R., Stiborová Marie, Vojtěšek Bořivoj, Adam Vojtěch, Zítka Ondřej, Eckschlager Tomáš, Kizek René2006-04-15:Determination of metallothionein content in patients with breast cancer, colon cancer, and malignant melanoma.
Klin Onkol 2006; 19(2): 143-146.
Keywords: ovarian cancer, lysophosphatidic acid, marker
Authors: Sedláková Iva, Vávrová Jiřina, Tošner Jindřich, Hanousek L.2006-04-15:Lysophosphatidic acid in ovarian carcinoma patients.
Keywords: ovarian cancer, lysophosphatidic acid, marker
Authors: Sedláková Iva, Vávrová Jiřina, Tošner Jindřich, Hanousek L.2006-04-15:Lysophosphatidic acid in ovarian carcinoma patients.